These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6765415)

  • 21. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R; Schröter G
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adhesive properties of Proteus genus related to antimicrobial agents resistance.
    Cellini L; Piccolomini R; Allocati N; Ravagnan G
    Microbiologica; 1987 Jul; 10(3):291-9. PubMed ID: 3626886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns.
    von Graevenitz A; Nourbakhsh M
    Med Microbiol Immunol; 1972; 157(2):142-8. PubMed ID: 4554514
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug resistance of Proteus vulgaris, Proteus morganii and Providencia rettgeri isolated from diagnostic specimens].
    Gołuszko P; Gospodarek E; Bugalski R
    Przegl Epidemiol; 1987; 41(3):319-23. PubMed ID: 3324173
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
    Fosse T; Soussy CJ; Duval J
    Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
    Iabadene H; Dallenne C; Messai Y; Geneste D; Bakour R; Arlet G
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4043-4. PubMed ID: 19546365
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of resistance to cephalosporins.
    Atkinson BA
    Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of semisynthetic penicillins against Proteeae.
    Hawkey PM; Pedler SJ; Turner A
    Antimicrob Agents Chemother; 1983 Apr; 23(4):619-21. PubMed ID: 6859841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.